REG vs TNGX · P/E 34, rev $1.45B vs $5.36B cap
Regency Centers Corporation (REG) versus Tango Therapeutics Inc (TNGX) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
REG currently screens at market cap $12.93B and trailing P/E 33.5. TNGX currently screens at market cap $5.36B.
Not investment advice. Open the REG and TNGX stock pages for the full models.
Not investment advice.